Combined immunotherapy for advanced prostate cancer: Empowering the T cell army

Combined immunotherapy for advanced prostate cancer: Empowering the T cell army

Bibliographic Details
Main Authors:	Sufyan Suleman, Gong-Hong Wei
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	Asian Journal of Urology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388217300462

Similar Items

Advances in Immunotherapy and Vaccine for Prostate Cancer
by: Wei Zhou, et al.
Published: (2023-06-01)

Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
by: Yuqing Pan, et al.
Published: (2024-04-01)

Progression in immunotherapy for advanced prostate cancer
by: Hao Liang, et al.
Published: (2023-02-01)

UMP and PERHEBAT to help empower former army personnel
by: Mohd Ferdaus, Musa
Published: (2019)

Immunotherapy in Prostate Cancer: Recent Advances and Future Directions
by: Ida Silvestri, et al.
Published: (2019-05-01)

Army of entrepreneurs : create an engaged and empowered workforce for exceptional business growth /
by: 520086 Prosek, Jennifer
Published: (2011)

Empowering therapeutic antibodies with IFN-α for cancer immunotherapy.
by: Jun Guo, et al.
Published: (2019-01-01)

Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions
by: Fernando López-Campos, et al.
Published: (2022-02-01)

How to empower the commanders of the army of the I.R. Iran in field of decision making
by: Mohammadhassan Ahmadzadehfard, et al.
Published: (2023-02-01)

How to Empower the Technical Inspectors of Islamic Republic of Iran Army Aviation (IRIAA)
by: Farhad Abolhassani, et al.
Published: (2021-02-01)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
by: Hanka Jähnisch, et al.
Published: (2010-01-01)

Advances in Prostate Cancer Immunotherapy: Current Options and Emerging Novel Approaches
by: Nasser S Alanazi, et al.
Published: (2024-10-01)

Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer
by: Yu Liu, et al.
Published: (2022-01-01)

Immunotherapy Vaccines for Prostate Cancer Treatment
by: Jide He, et al.
Published: (2024-10-01)

Research Progress on Combination of Radiotherapy and Immunotherapy on Advanced Non-small Cell Lung Cancer with Negative Driver Genes
by: LI Peng, et al.
Published: (2023-09-01)

Advances in Combined Immunotherapy for Triple Negative Breast Cancer
by: WANG Hua, et al.
Published: (2022-10-01)

333 Empowering cancer immunotherapy by mesothelin-directed CAR T cells engineered to secret checkpoint inhibitors
by: Jiantao Wang, et al.
Published: (2023-11-01)

Advancing non-small cell lung cancer treatment: the power of combination immunotherapies
by: Yuanlin Wu, et al.
Published: (2024-07-01)

First-line Combination Immunotherapy in Advanced Non-small Cell Lung Cancer
by: Xiaoxiao PENG, et al.
Published: (2018-12-01)

Empowering Women and Children: Pakistan Army Female Engagement Team’s Vital Role in UN Peacekeeping
by: Talat Yasmin
Published: (2024-01-01)

Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
by: Yang Xu, et al.
Published: (2022-06-01)

Combining Androgen Deprivation and Immunotherapy in Prostate Cancer Treatment: A Mechanistic Approach
by: Johnna Barnaby, et al.
Published: (2022-07-01)

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review
by: Felicity C. Martin, et al.
Published: (2023-04-01)

Current Update on Prostate Cancer Immunotherapy
by: Juliana E. Kim, et al.
Published: (2023-03-01)

Is There a Role for Immunotherapy in Prostate Cancer?
by: Alessandro Rizzo, et al.
Published: (2020-09-01)

The Cellular and Molecular Immunotherapy in Prostate Cancer
by: Anirban Goutam Mukherjee, et al.
Published: (2022-08-01)

Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
by: Kaisheng You, et al.
Published: (2024-06-01)

Editorial: Advances in immunotherapy and combination therapy for biliary tract cancers
by: Chengpei Zhu, et al.
Published: (2024-01-01)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
by: Irene Moya-Horno, et al.
Published: (2018-01-01)

Advancements in Radiomics for Immunotherapy of Non-small Cell Lung Cancer
by: Yue HOU, et al.
Published: (2024-08-01)

Granulomatous prostatitis after intravesical immunotherapy mimicking prostate cancer
by: Waldemar Białek, et al.
Published: (2016-12-01)

MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
by: Jing Ren, et al.
Published: (2012-01-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
by: Kuang Youlin, et al.
Published: (2012-01-01)

New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer
by: Mingen Lin, et al.
Published: (2023-06-01)

First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer
by: John Prior, et al.
Published: (2022-10-01)

Advancements in Cancer Immunotherapies
by: Ruchi Roy, et al.
Published: (2022-12-01)

Update on combined immunotherapy for the treatment of advanced renal cell carcinoma
by: Georges Gebrael, et al.
Published: (2023-01-01)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
by: Daniel P. Petrylak, et al.
Published: (2016-12-01)

A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy
by: Chen S, et al.
Published: (2024-10-01)